RCM

RA Capital Management Portfolio holdings

AUM $9.76B
1-Year Est. Return 103.63%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+103.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.3B
AUM Growth
+$879M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
63
New
Increased
Reduced
Closed

Top Buys

1
+$371M
2
+$250M
3
+$73.8M
4
NAMS icon
NewAmsterdam Pharma
NAMS
+$66.3M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$56.5M

Top Sells

1
+$231M
2
+$91M
3
+$62.4M
4
HLVX
HilleVax
HLVX
+$29.1M
5
KNTE
Kinnate Biopharma Inc. Common Stock
KNTE
+$26.7M

Sector Composition

1 Healthcare 99.99%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
51
$7.9M 0.15%
6,991,003
52
$7.09M 0.13%
+233,318
53
$6.98M 0.13%
1,723,373
-733,900
54
$697K 0.01%
333,333
55
– –
-1,734,972
56
– –
-1,760,019
57
– –
-1,131,775
58
– –
-590,218
59
– –
-659,992
60
– –
-4,264,144
61
– –
-12,643,574
62
– –
-5,914,252
63
– –
-295,966
1 2
3